Clinical Trials

38 enrolled

Adenomatous Polyposis Coli, Colorectal Neoplasms

NCT06732388 2026-03-18

Itraconazole in Combination With Ablation for the Prevention of Esophageal Cancer in Patients With High-risk Barrett's Esophagus

64 enrolled

Adenocarcinoma Of Esophagus, Barrett Esophagus

NCT06735638 2026-03-18

Outside the Cage (OTC) Robotic Esophagectomy

31 enrolled

Esophageal Neoplasms, Ornithine Carbamoyltransferase Deficiency Disease

NCT07464236 2026-03-18

PEACHES 2

8 enrolled

Anus Neoplasms, Chlamydia Infections, Gonorrhea

NCT07470268 2026-03-18

HY-PANC

10 enrolled

Motor Activity, Pancreatic Neoplasms

NCT07472933 2026-03-18

Vebotolimab Combined With Ptorlimab for EGFR-positive Refractory Advanced Biliary Tract Malignancies

44 enrolled

Cancer of Biliary Duct

NCT07479381 2026-03-18

CLEAR

1,450 enrolled

Disease, Neoplasms, Colorectal Neoplasms

NCT07479472 2026-03-18

YOGICO

150 enrolled

Early-onset Gastrointestinal Cancer

NCT07479485 2026-03-18

MRG006A Combination Therapy for Advanced Hepatocellular Carcinoma (Phase I/II)

160 enrolled

Carcinoma, Hepatocellular

NCT07481032 2026-03-18

Effect of Fufang Biejiaruangan Combined With Antiviral Therapy on the Incidence of Hepatocellular Carcinoma in Patients With Hepatitis B-related Cirrhosis: A Multicenter, Randomized, Placebo-controlled Study

1,034 enrolled

Carcinoma, Hepatocellular, Liver Cirrhosis, Hepatitis B, Chronic

NCT07481357 2026-03-18

A First-In-Human Phase I/IIa Study to Evaluate DA 3501 in Patients With Advanced Gastric or Gastro-esophageal Junction Adenocarcinoma and Pancreatic Ductal Adenocarcinoma

51 enrolled

Stomach Neoplasms

NCT07476651 2026-03-17

LASER

Carcinoma, Hepatocellular, Cholangiocarcinoma

NCT07477444 2026-03-17

HER-OIC

29 enrolled

Gastroesophageal Cancer

NCT07478185 2026-03-17

Prehab for Pancreatic Cancer Surgery

20 enrolled

Pancreatic cancer, adult, Pancreatic Neoplasms

NCT07478523 2026-03-17

FAPDIG

120 enrolled

Cholangiocarcinoma

NCT07416552 2026-03-16

A Study to Investigate CEA-PRIT 2.0 in Participants With Metastatic Colorectal Cancer (mCRC)

180 enrolled

Colorectal Neoplasms

NCT07419841 2026-03-16

A Phase 1 Study of the Safety and Tolerability of CTX-10726

GastrointestinalGenitourinaryGynecologic

70 enrolled

Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Endometrial Neoplasms

NCT07474025 2026-03-16

Integrating Peritoneal Histological Growth Patterns Into Preoperative Decision-Making for Colorectal Peritoneal Metastses

Colonic Neoplasms, Neoplasm Metastasis, Neoplasms, Colorectal Neoplasms

NCT07469306 2026-03-13

Short-Course RT Plus CAPOX and Tislelizumab vs Long-Course CRT Plus Tislelizumab for Locally Advanced Rectal Cancer

130 enrolled

Locally Advanced Rectal Cancer

NCT07469956 2026-03-13

Surufatinib Plus mFOLFIRINOX and PD-1 Inhibitor as the Neoadjuvant Therapy for High-risk or Borderline Resectable Pancreatic Cancer

Pancreatic Neoplasms

NCT07296887 2026-03-12

CARE Tool Study Aim 3

GastrointestinalGenitourinaryThoracic

430 enrolled

Financial Stress, Lung Neoplasms, Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

NCT07391670 2026-03-12

IMFINZI-subQ

40 enrolled

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Hepatocellular, Small Cell Lung Carcinoma

NCT07411599 2026-03-12

Dual Administration Of Intraperitoneal And Intravenous TROP2-Directed CAR-NK With TGF-Beta Receptor 2 (TGFBR2) Knock Out (KO) Therapy For Colorectal Cancer-Related Peritoneal Carcinomatosis: A Phase 1/2 Trial ("Chip-CRC Trial")

28 enrolled

Colorectal Cancer, Hereditary Nonpolyposis, Type 6, Carcinoma, Colorectal Neoplasms

NCT07436988 2026-03-12

ReLIVE

18 enrolled

Carcinoma, Hepatocellular, Liver Neoplasms

NCT07450976 2026-03-12

A Study of SHR-A1904 in Previous Systemic Treatment Failed Biliary Tract Cancer

151 enrolled

Biliary Tract Neoplasms

NCT07466225 2026-03-12

HAIC Plus Lenva and PD-1 for Advanced HCC With Macrovascular or Biliary Invasion

150 enrolled

Carcinoma, Hepatocellular

NCT07466238 2026-03-12

HAIC Plus Systemic Therapy as De-escalation Therapy Strategy for Biliary Tract Cancer

40 enrolled

Phase 4 Not yet recruiting

Biliary Tract Neoplasms

NCT07467174 2026-03-12

REPROG-RCT

538 enrolled

Stomach Neoplasms

NCT07467434 2026-03-12

SYNCHRONOX

550 enrolled

Rectal Neoplasms

NCT07467590 2026-03-12

TRIUNITE-07

33 enrolled

Colorectal Neoplasms

NCT07468071 2026-03-12

KontRASt-R

40 enrolled

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms

NCT07381634 2026-03-11

The Safety and Efficacy of Ondansetron in Reducing Immune Checkpoint Inhibitor-Related Toxicities

134 enrolled

Carcinoma, Hepatocellular

NCT07463248 2026-03-11

PULSAR Combined With Fecal Microbiota Transplantation for Advanced Hepatocellular Carcinoma Progressing After First-Line Targeted-Immunotherapy

64 enrolled

Carcinoma, Hepatocellular

NCT07463261 2026-03-11

RELOAD

442 enrolled

Phase 3 Not yet recruiting

Rectal Neoplasms, Anastomotic Leak

NCT07463573 2026-03-11

QLC5508 vs. Chemotherapy in Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma

466 enrolled

Esophageal Squamous Cell Carcinoma

NCT07463690 2026-03-11

Construction and Evaluation of a Flipped Discharge Model for Stomates With Colorectal Cancer

200 enrolled

Colorectal Neoplasms

NCT07464756 2026-03-11

SHR-1701 With or Without Apatinib in Combination With Chemotherapy as Neoadjuvant Therapy for Gastric Cancer

80 enrolled

Gastric Adenocarcinoma

NCT07464769 2026-03-11

KompXX

Phase 3 Not yet recruiting

358 enrolled

BreastGastrointestinal

Breast Neoplasms, Colorectal Neoplasms

NCT07461675 2026-03-10

Effects of Neoadjuvant Immunotherapy on Anti-tumour Immunity in Hepatocellular Carcinoma Patients Undergoing Liver Resection

Phase 2/3 Not yet recruiting

Carcinoma, Hepatocellular

NCT07462143 2026-03-10

A Phase Ⅱ/Ⅲ Clinical Trial of RC148 Plus Chemotherapy as 1L Therapy for Unresectable or Metastatic Colorectal Cancer

700 enrolled

Colonic Neoplasms

NCT07459309 2026-03-09

Clinical Study on the Safety, Efficacy, and Exploration of Immune Mechanisms of a Combined Multimodal Tumor Therapy System for Hepatic Malignancies

20 enrolled

Liver Neoplasms, Neoplasm Metastasis

NCT07191418 2026-03-06

Spearmint

178 enrolled

Pancreatic Cancer Metastatic to Liver

NCT07436637 2026-03-06

Guardant Shield Colorectal Cancer Screening

500 enrolled

Colorectal Neoplasms

NCT07453394 2026-03-06

QLS5132 Combination Therapy in Advanced Solid Tumors

GastrointestinalGynecologicThoracic

626 enrolled

Carcinoma, Non-Small-Cell Lung, Ovarian Neoplasms, Stomach Neoplasms, Endometrial Neoplasms

NCT07453797 2026-03-06

VISION

150 enrolled

Colorectal Neoplasms

NCT07453875 2026-03-06

TRIUNITE06

9 enrolled

Colorectal Neoplasms

NCT07454486 2026-03-06

TRACE-BTC

300 enrolled

Phase 2/3 Not yet recruiting

Biliary Tract Neoplasms, Gallbladder Neoplasms, Neoplasms, Cholangiocarcinoma, Klatskin Tumor, Neoplasm, Residual

NCT07454720 2026-03-06

A Randomized, Double-blind, Placebo-controlled, Multicenter Phase II/III Clinical Study of Adebrelimab in Combination With SHR-8068 and Chemoradiotherapy as Perioperative Therapy for Locally Advanced Rectal Cancer

165 enrolled

Locally Advanced Resectable Rectal Cancer

NCT07455422 2026-03-06

Endeavor-2

266 enrolled